|Bid||0.00 x 900|
|Ask||0.00 x 1400|
|Day's Range||24.56 - 25.32|
|52 Week Range||20.22 - 38.52|
|Beta (3Y Monthly)||1.27|
|PE Ratio (TTM)||14.18|
|Forward Dividend & Yield||1.04 (4.37%)|
|1y Target Est||N/A|
This article is intended for those of you who are at the beginning of your investing journey and want to begin learning about how to value company based on its Read More...
Shares of Patterson Companies Inc (NASDAQ:PDCO) will begin trading ex-dividend in 4 days. To qualify for the dividend check of US$0.26 per share, investors must have owned the shares prior Read More...
On CNBC's "Mad Money Lightning Round" , Jim Cramer said he's still not ready to call a bottom in Lam Research Corporation (NASDAQ: LRCX ). Cramer thinks the price is right to pull the trigger ...
Jim Cramer rattles off his take on callers' favorite stocks, including a cloud play that's been experiencing some stormy weather.
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Patterson Companies Inc (NASDAQ:PDCO), with a market cap of US$2.30b, are often out of theRead More...
Shares of Patterson Companies Inc. (pdco) plunged as much as 15% to a nine-year low in intraday trade, before bouncing to be down 5.8% in active afternoon trade, in the wake of the dental and animal health markets company's fiscal first-quarter results. Excluding non-recurring items, adjusted earnings per share came to 26 cents, below the FactSet consensus of 34 cents. Sales increased to $1.34 billion from $1.30 billion, above the FactSet consensus of $1.30 billion, as both dental supply and animal health sales topped expectations.
Patterson Companies Inc. tumbled to a nine-year low after fiscal first-quarter results at the distributor to dentists and veterinarians flashed warning signs for pricing across the dental-supplies industry....
Patterson Companies' (PDCO) adjusted earnings declines considerably on a year-over-year basis in Q1. Lackluster performance by the dental unit is a concern.
Medical goods supplier Henry Schein Inc. (hsix) said Thursday it expects to settle class-action litigation in a case brought in New York and will book a charge in the third quarter. The case, Re Dental Supplies Antitrust Litigation, No. 1:16-CV-00696-BMC-GRB, in the United States District Court for the Eastern District of New York, alleges that the company and others violated antitrust rules by fixing prices on dental equipment, among other issues. The settlement is subject to a definitive agreement among the parties, and approval by the court.
Integer Holdings (ITGR) gains on strong quarterly performance. The company is likely to gain from the Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets.
Cerner (CERN) launches new Risk Calculator app that will check cardiac risk. The company's relentless efforts to digitize its EHR systems is commendable.
Solid demand for Medtronic's (MDT) quadripolar cardiac resynchronization therapy-pacemakers (CRT-P) along with growth in Mechanical Circulatory Support drives Heart Failure division revenues.
Strong performance in the World Courier Business is likely to provide AmerisourceBergen (ABC) a competitive edge in the MedTech space.
Align Technology's (ALGN) Invisalign Technology prospects and growth in North America and outside hold great potential for the stock, particularly in the Asia-Pacific and EMEA regions.
Within Chemed's (CHE) VITAS business, management notes the recent admission trends to be consistently positive and this momentum is likely to continue.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.